Researchers report that AI-designed peptides are revolutionizing drug discovery by rapidly generating candidates that were previously unimagined. These advances, highlighted by experts including Peter ‘t Hart, are transforming workflows in peptide synthesis and targeting RNA-protein interactions. However, the acceleration comes with sustainability challenges related to increased water use and emissions. The integration of AI with experimental validation heralds a new era in peptide therapeutics, balancing innovation with environmental considerations.